# High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects

Review · Nicolas Villain, Vincent Planche, Richard Lévy

- Archive id: doi:10.1016/j.neurol.2022.06.012
- Published: 2022-09-29
- Venue: Revue Neurologique
- DOI: https://doi.org/10.1016/j.neurol.2022.06.012
- PMID: 36184326
- Citations: 87
- Source URL: https://doi.org/10.1016/j.neurol.2022.06.012
- PDF: https://www.sciencedirect.com/science/article/pii/S003537872200738X/pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.